Semaglutide 5mg

What Is Dragon Pharma Semaglutide 5mg?

Dragon Pharma Semaglutide 5mg is a GLP-1 receptor agonist peptide supplied as a lyophilised (freeze-dried) powder in a single vial. Semaglutide is the active compound used in branded prescription medications for type 2 diabetes and chronic weight management. It works by mimicking the incretin hormone GLP-1, which reduces appetite, slows gastric emptying, and regulates blood sugar levels.

This product is intended for research purposes. Each vial contains 5mg of Semaglutide and requires reconstitution with bacteriostatic water before use. Ships with an anti-counterfeit verification code. Verify your batch.

What Are the Key Specs?

• Active compound: Semaglutide 5mg per vial
• Form: Lyophilised powder (requires reconstitution)
• Half-life: Approximately 7 days (once-weekly dosing)
• Storage: Refrigerate (2-8C) before and after reconstitution
• Administration: Subcutaneous injection
• Manufacturer: Dragon Pharma (European production)

How Is Semaglutide Typically Dosed in Research?

Research protocols typically start at 0.25mg per week for the first 4 weeks, increasing to 0.5mg per week, then 1mg per week, and potentially up to 2.4mg per week depending on tolerance and goals. The long 7-day half-life supports once-weekly subcutaneous administration.

How Does Semaglutide Compare to Tirzepatide?

Semaglutide is a single-agonist (GLP-1 only), while Tirzepatide is a dual-agonist (GIP + GLP-1) and Retatrutide is a triple-agonist (GIP + GLP-1 + Glucagon). Semaglutide has the longest research track record of the three. All are available in our peptides category.

All peptides ship cold-packed from our UK warehouse. Full lab data in our Dragon Pharma Review 2026.